Target intelligence / Profile preview

Clostridioides difficile toxin receptors

Molecular classification
Receptor, G protein-coupled receptor, Proteoglycan, Cell adhesion molecule, Enzyme, Other
01

Overview

The intestinal epithelial brush border receptors for Clostridioides difficile toxins are a group of host cell surface proteins and glycans that mediate the entry of Toxin A (TcdA) and Toxin B (TcdB) into colonic epithelial cells. TcdB, the primary driver of human disease, utilizes Frizzled receptors (specifically FZD1, FZD2, and FZD7), Chondroitin sulfate proteoglycan 4 (CSPG4), and Poliovirus receptor-related 3 (PVRL3/Nectin-3) for cell attachment and endocytosis. TcdA interacts with various glycans, glycoprotein 96 (gp96), and members of the low-density lipoprotein receptor family. These receptors are primarily located on the apical brush border of intestinal epithelial cells, where they serve as the initial contact points for luminal toxins. Following receptor binding, the toxins are internalized via endocytosis and subsequently glucosylate Rho-family GTPases, causing cytoskeletal disruption, loss of barrier function, and cell death. Therapeutic strategies targeting these receptors include neutralizing antibodies like bezlotoxumab, which prevents TcdB from binding to its host receptors, and experimental decoy receptors designed to sequester toxins before they can reach the epithelial surface.

Other names
Intestinal epithelial brush border receptors for C. difficile toxinsClostridioides difficile toxin receptorsTcdA receptorsTcdB receptorsFrizzled receptors (FZD1, FZD2, FZD7)Chondroitin sulfate proteoglycan 4 (CSPG4)Poliovirus receptor-related 3 (PVRL3)Nectin-3Glycoprotein 96 (gp96)Sucrase-isomaltase (SI)Low-density lipoprotein receptor (LDLR)Low-density lipoprotein receptor-related protein 1 (LRP1)
02

Mechanism of action

Toxin neutralization, Competitive inhibition of receptor binding, Blocking endocytosis

03

Biological functions

Signal transductionCell adhesionWnt signalingEndocytosisCarbohydrate metabolism
04

Disease associations

InfectionInflammationClostridioides difficile infection (CDI)Pseudomembranous colitisToxic megacolon
05

Safety considerations

Disruption of Wnt signalingImpaired intestinal stem cell regenerationToxin escape mutationsOff-target effects of direct receptor blockade
06

Interacting drugs

Bezlotoxumab

3 more in the full profile.

07

Biomarkers

C. difficile toxin A/B presence in stoolFZD7 expression levelsCSPG4 expression levels

Beyond the preview

Go deeper on Clostridioides difficile toxin receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile toxin receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call